Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients’ survival
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients’ survival ; volume:11 ; number:1 ; day:14 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
Scientific reports ; 11, Heft 1 (14.1.2021), 1-9, 12.2021
- Creator
-
Jung, Woon Yong
Min, Kyueng-Whan
Oh, Young Ha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-79907-6
- URN
-
urn:nbn:de:101:1-2021020823161775282862
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jung, Woon Yong
- Min, Kyueng-Whan
- Oh, Young Ha
- SpringerLink (Online service)
Other Objects (12)
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genetic variation determines VEGF-A plasma levels in cancer patients
Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro
VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway
Combining anti-Ang-2/VEGF-A therapy with radio- and chemotherapy in glioma
The impact of KRAS mutations on VEGF-A production and tumour vascular network
How VEGF-A and its splice variants affect breast cancer development – clinical implications
Die Rolle von VEGF-A beim Kollateralenwachstum in einem Autoimmundiabetes-Modell der Maus
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genetic variation determines VEGF-A plasma levels in cancer patients
Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro
VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway
Combining anti-Ang-2/VEGF-A therapy with radio- and chemotherapy in glioma
The impact of KRAS mutations on VEGF-A production and tumour vascular network
How VEGF-A and its splice variants affect breast cancer development – clinical implications
Die Rolle von VEGF-A beim Kollateralenwachstum in einem Autoimmundiabetes-Modell der Maus
Untersuchungen zur transkriptionellen Regulation von vegf-A und vegf-D in humanen Magenkarzinomzellen
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genetic variation determines VEGF-A plasma levels in cancer patients
Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro
VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway
Combining anti-Ang-2/VEGF-A therapy with radio- and chemotherapy in glioma
The impact of KRAS mutations on VEGF-A production and tumour vascular network
How VEGF-A and its splice variants affect breast cancer development – clinical implications